- Home
- SNY vs RUN Comparison
SNY vs RUN Comparison
Compare SNY & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RUN
- Stock Information
- Founded
- SNY 1994
- RUN 2007
- Country
- SNY France
- RUN United States
- Employees
- SNY N/A
- RUN N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RUN Industrial Machinery/Components
- Sector
- SNY Health Care
- RUN Miscellaneous
- Exchange
- SNY Nasdaq
- RUN Nasdaq
- Market Cap
- SNY 113.4B
- RUN 3.7B
- IPO Year
- SNY N/A
- RUN 2015
- Fundamental
- Price
- SNY $46.61
- RUN $16.45
- Analyst Decision
- SNY Buy
- RUN Buy
- Analyst Count
- SNY 4
- RUN 20
- Target Price
- SNY $61.50
- RUN $16.35
- AVG Volume (30 Days)
- SNY 2.8M
- RUN 12.9M
- Earning Date
- SNY 10-24-2025
- RUN 11-06-2025
- Dividend Yield
- SNY 3.43%
- RUN N/A
- EPS Growth
- SNY 118.56
- RUN N/A
- EPS
- SNY 8.65
- RUN N/A
- Revenue
- SNY $53,714,621,258.00
- RUN $2,129,272,000.00
- Revenue This Year
- SNY $1.53
- RUN $11.84
- Revenue Next Year
- SNY $7.06
- RUN $8.69
- P/E Ratio
- SNY $5.39
- RUN N/A
- Revenue Growth
- SNY 15.65
- RUN 3.27
- 52 Week Low
- SNY $44.73
- RUN $5.38
- 52 Week High
- SNY $60.12
- RUN $21.77
- Technical
- Relative Strength Index (RSI)
- SNY 40.69
- RUN 59.77
- Support Level
- SNY $46.79
- RUN $15.83
- Resistance Level
- SNY $47.69
- RUN $17.27
- Average True Range (ATR)
- SNY 0.68
- RUN 1.01
- MACD
- SNY -0.26
- RUN -0.23
- Stochastic Oscillator
- SNY 27.40
- RUN 44.51
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.